Product image of Bortezomib Eg (Bortezomib) supplied by GNH India

Bortezomib Eg

Active Ingredient:
Bortezomib
Origin:
EU

Bortezomib Eg (Bortezomib)

Bortezomib Eg is a pharmaceutical product used for intravenous or subcutaneous administration. It belongs to a class of drugs known as proteasome inhibitors, often utilized in specific medical treatments.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bortezomib Eg is primarily used as a proteasome inhibitor. It is commonly prescribed for the treatment of certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. The drug works by interfering with the growth of cancer cells, making it a key component in targeted therapy regimens.

Side Effects

  • Common effects of Bortezomib Eg may include fatigue, nausea, and peripheral neuropathy. Some individuals might experience diarrhea or constipation. It is important to monitor for any adverse reactions and consult a healthcare provider if severe side effects occur.

Precautions & Warnings

  • Bortezomib Eg should be handled with care, especially when preparing for intravenous or subcutaneous use. It is essential to follow proper storage and administration guidelines to ensure safety. Patients with pre-existing conditions should discuss their medical history with a healthcare provider before starting treatment.

Avoid Interactions

  • Bortezomib Eg may interact with other medications, including those that affect liver enzymes. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the drug's effectiveness.

Frequently Asked Questions

Bortezomib Eg is used primarily in the treatment of certain types of cancer, such as multiple myeloma and mantle cell lymphoma.

Bortezomib Eg can be administered either intravenously or subcutaneously, depending on the prescribed treatment plan.

Common side effects may include fatigue, nausea, peripheral neuropathy, diarrhea, and constipation.

It is important to consult a healthcare provider before combining Bortezomib Eg with other medications to avoid potential interactions.

Precautions include proper handling and administration, following storage guidelines, and discussing medical history with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT